Economic models of hepatitis a virus immunization
Martin Meltzer
Ph.D.
Senior Health Economist, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, Acting Chief and Economist, Prevention Effectiveness Branch, Centers for Disease Control and Prevention, Atlanta, GA
Search for more papers by this authorMark L. Messonnier
Ph.D.
Senior Health Economist, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, Acting Chief and Economist, Prevention Effectiveness Branch, Centers for Disease Control and Prevention, Atlanta, GA
Search for more papers by this authorMartin Meltzer
Ph.D.
Senior Health Economist, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, Acting Chief and Economist, Prevention Effectiveness Branch, Centers for Disease Control and Prevention, Atlanta, GA
Search for more papers by this authorMark L. Messonnier
Ph.D.
Senior Health Economist, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, Acting Chief and Economist, Prevention Effectiveness Branch, Centers for Disease Control and Prevention, Atlanta, GA
Search for more papers by this author
References
- 1 Das A. An economic analysis of different strategies of immunization against hepatitis A virus in developed countries. Hepatology 1999; 29: 548–552. MEDLINE
- 2 Fryback DG, Lawrence WF. Dollars may not buy as many QALYs as we think: a problem with defining quality-of-life adjustments. Med Decision Making 1997; 17: 276–284.
- 3 Gold MR, Franks P, McCoy K, Fryback DG. Toward consistency in cost-utility analyses: using national measures to create condition-specific values. Med Care 1998; 36: 778–792. MEDLINE
- 4 Centers for Disease Control and Prevention. Hepatitis surveillance. Report number 56. Atlanta, GA, 1996.
- 5 Smith S, Weber S, Wiblin T, Nettleman M. Cost-effectiveness of hepatitis A vaccination in healthcare workers. Infect Control Hosp Epidemiol 1997; 18: 688–691. MEDLINE
- 6 Patrick D, Erickson P. Health status and health policy: quality of life in health care evaluation and resource allocation. New York: Oxford University Press, 1993.
- 7 Das A. An economic analysis of different strategies of immunization against hepatitis a virus in developed countries. Hepatology 1999; 29: 548–552. MEDLINE
- 8 Lemon SM, Schapiro CN. The value of immunization against hepatitis A. Infect Agents Dis 1994; 1: 38–49.
- 9 Centers for Disease Control and Prevention. Morbidity and Mortality Weekly Report 1996; 45: 4.
- 10 O'Connor JFB, Imperiale TF, Singer ME. Hepatitis A vaccination for average risk persons: is there a role? [Abstract] Am J Gastroenterol 1997; 92: 1721.
- 11 Das A. An economic analysis of different strategies of immunization against hepatitis A virus in developed countries. Hepatology 1999; 29: 548–552. MEDLINE
- 12 Dalton CB, Haddix A, Hoffman RE, Mast EE. The costs of a food-borne outbreak of hepatitis A in Denver, Colorado. Arch Intern Med 1996; 156: 1013–1016. MEDLINE
